ET-26 compound: Clinical Trials

4 trials of ET-26 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1
Phase 31Not yet recruiting 1

Follow ET-26 compound: new trials by email Literature Review of ET-26 compound trials Research Report on ET-26 compound

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy
ET-26HCl 0.8mg/kg group, Etomidate Injectable Product 0.3mg/kg group - Gastroscopy, Colonoscopy
Phase 3Not yet recruitingAhon Pharmaceutical Co., Ltd.2702025-03-012025-03-05
A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy
ET-26HCl 0.6mg/kg group, ET-26HCl 0.8mg/kg group, Etomidate Injectable Product 0.3mg/kg group - Gastroscopy, Colonoscopy
Phase 2CompletedAhon Pharmaceutical Co., Ltd.782024-11-152025-05-25
Safety and Pharmacokinetics/ Pharmacodynamics of Methoxyethyl Etomidate Hydrochloride in Healthy Elderly Subjects
ET-26HCl - Healthy Elderly Subjects
Phase 1CompletedAhon Pharmaceutical Co., Ltd.162023-12-252025-01-24
Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride
ET-26HCl - Renal Insufficiency
Phase 1CompletedAhon Pharmaceutical Co., Ltd.242023-11-302024-12-27

Conditions studied

Renal Insufficiency (1)

Sponsors

Ahon Pharmaceutical Co., Ltd. (4)

Countries

China (4)

Top investigators

Mengchang Yang (2)  ·  Wei Zhao, Pharmaciae Doctor (2)  ·  Jin Liu (1)